Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus-Reference-Cited by-同舟云学术

Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus

Published:2017-06 Issue: Volume:5 Page:62-74
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Illingworth Sam,Di Ying,Bauzon Maxine,Lei Janet,Duffy Margaret R.,Alvis Simon,Champion Brian,Lieber André,Hermiston Terry,Seymour Len W.,Beadle John,Fisher Kerry

Funder

PsiOxus Therapeutics

Cancer Research UK

Schering AG

Bayer Healthcare

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference45 articles.

1. Directed evolution generates a novel oncolytic virus for the treatment of colon cancer;Kuhn;PLoS ONE,2008

2. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity;Vogels;J. Virol.,2003

3. Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood;Di;Gene Ther.,2014

4. The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues;Thorsteinsson;APMIS,1998

5. Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer;Shang;Arch. Pathol. Lab. Med.,2014

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the therapeutic study of oncolytic virus in colorectal cancer;Oncology and Translational Medicine;2024-07-02

2. Arming oncolytic viruses with bispecific T cell engagers: The evolution and current status;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

3. Toward the understanding of DSG2 and CD46 interaction with HAdV-11 fiber, a super-complex analysis;Journal of Virology;2023-11-30

4. Oncolytic viruses against cancer, promising or delusion?;Medical Oncology;2023-07-17

5. The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade;Biomedicine & Pharmacotherapy;2023-05